{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:54:02Z","timestamp":1776128042301,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,11,22]],"date-time":"2017-11-22T00:00:00Z","timestamp":1511308800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,11,22]],"date-time":"2017-11-22T00:00:00Z","timestamp":1511308800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Clopidogrel is an antiplatelet medicine used to prevent blood clots in patients who have had a heart attack, stroke, or other symptoms. Variability in the clinical response to clopidogrel treatment has been attributed to genetic factors. In particular, five SNPs of rs4244285, rs4986893, rs12248560, rs662 and rs1045642 have been associated with resistance to clopidogrel therapy in Chinese population. This work involves the development of a multiplex high-resolution melting (HRM) assay to genotype all five of these loci in 2 tubes. Amplicons corresponding to distinct SNPs in a common tube were designed with the aid of uMelt prediction software to have different melting temperatures Tm by addition of a GC-rich tail to the 5\u2032 end of the certain primers. Two kinds of commercial methods, Digital Fluorescence Molecular Hybridization (DFMH) and Sanger sequencing, were used as a control. Three hundred sixteen DFMH pretested samples from consecutive acute coronary syndrome patients were used for a blinded study of multiplex HRM. The sensitivity of HRM was 100% and the specificity was 99.93% reflecting detection of variants other than the known resistance SNPs. Multiplex HRM is an effective closed-tube, highly accurate, fast, and inexpensive method for genotyping the 5 clopidogrel resistance associated SNPs.<\/jats:p>","DOI":"10.1038\/s41598-017-16310-8","type":"journal-article","created":{"date-parts":[[2017,11,16]],"date-time":"2017-11-16T10:59:28Z","timestamp":1510829968000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["A Novel Multiplex HRM Assay to Detect Clopidogrel Resistance"],"prefix":"10.1038","volume":"7","author":[{"given":"Lichen","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0105-732X","authenticated-orcid":false,"given":"Xiaowei","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoling","family":"You","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoqing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qihua","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,11,22]]},"reference":[{"key":"16310_CR1","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/S0140-6736(01)05701-4","volume":"358","author":"SR Mehta","year":"2001","unstructured":"Mehta, S. R. et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. The Lancet 358, 527\u2013533, https:\/\/doi.org\/10.1016\/s0140-6736(01)05701-4 (2001).","journal-title":"The Lancet"},{"key":"16310_CR2","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1016\/j.jacc.2006.11.044","volume":"49","author":"DJ Angiolillo","year":"2007","unstructured":"Angiolillo, D. J. et al. Variability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectives. J Am Coll Cardiol 49, 1505\u20131516, https:\/\/doi.org\/10.1016\/j.jacc.2006.11.044 (2007).","journal-title":"J Am Coll Cardiol"},{"key":"16310_CR3","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1160\/TH06-08-0420","volume":"97","author":"J Siller-Matula","year":"2007","unstructured":"Siller-Matula, J., Schror, K., Wojta, J. & Huber, K. Thienopyridines in cardiovascular disease: focus on clopidogrel resistance. Thrombosis and haemostasis 97, 385\u2013393, https:\/\/doi.org\/10.1160\/TH06-08-0420 (2007).","journal-title":"Thrombosis and haemostasis"},{"key":"16310_CR4","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.ahj.2008.09.013","volume":"157","author":"G Lemesle","year":"2009","unstructured":"Lemesle, G. et al. Impact of high loading and maintenance dose of clopidogrel within the first 15 days after percutaneous coronary intervention on patient outcome. Am Heart J 157, 375\u2013382, https:\/\/doi.org\/10.1016\/j.ahj.2008.09.013 (2009).","journal-title":"Am Heart J"},{"key":"16310_CR5","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.rec.2011.09.026","volume":"65","author":"TO Bergmeijer","year":"2012","unstructured":"Bergmeijer, T. O. & ten Berg, J. M. Value of CYP2C19 *2 and *17 Genotyping in Clinical Practice. Promising but Not Ready Yet. Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition) 65, 205\u2013207, https:\/\/doi.org\/10.1016\/j.rec.2011.09.026 (2012).","journal-title":"Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)"},{"key":"16310_CR6","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.clpt.2006.07.007","volume":"80","author":"D Taubert","year":"2006","unstructured":"Taubert, D. et al. Impact of P-glycoprotein on clopidogrel absorption. Clinical pharmacology and therapeutics 80, 486\u2013501, https:\/\/doi.org\/10.1016\/j.clpt.2006.07.007 (2006).","journal-title":"Clinical pharmacology and therapeutics"},{"key":"16310_CR7","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/nm0111-40","volume":"17","author":"EJ Topol","year":"2011","unstructured":"Topol, E. J. & Schork, N. J. Catapulting clopidogrel pharmacogenomics forward. Nature medicine 17, 40\u201341, https:\/\/doi.org\/10.1038\/nm0111-40 (2011).","journal-title":"Nature medicine"},{"key":"16310_CR8","doi-asserted-by":"publisher","unstructured":"Frelinger, A. L. III et al. Clopidogrel pharmacokinetics and pharmacodynamics vary widely despite exclusion or control of polymorphisms (CYP2C19, ABCB1, PON1), noncompliance, diet, smoking, co-medications (including proton pump inhibitors), and pre-existent variability in platelet function. Journal of the American College of Cardiology 61, 872\u2013879, https:\/\/doi.org\/10.1016\/j.jacc.2012.11.040 (2013).","DOI":"10.1016\/j.jacc.2012.11.040"},{"key":"16310_CR9","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/265687a0","volume":"265","author":"F Sanger","year":"1977","unstructured":"Sanger, F. et al. Nucleotide sequence of bacteriophage phi X174 DNA. Nature 265, 687\u2013695 (1977).","journal-title":"Nature"},{"key":"16310_CR10","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1016\/j.thromres.2014.10.001","volume":"134","author":"S Zhang","year":"2014","unstructured":"Zhang, S. et al. VASP phosphorylation and genetic polymorphism for clopidogrel resistance in Chinese patients with non-cardioembolic ischemic stroke. Thrombosis research 134, 1272\u20131277 (2014).","journal-title":"Thrombosis research"},{"key":"16310_CR11","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1111\/j.1538-7836.2007.02722.x","volume":"5","author":"P Fontana","year":"2007","unstructured":"Fontana, P., Hulot, J. S., De Moerloose, P. & Gaussem, P. Influence of CYP2C19 and CYP3A4 gene polymorphisms on clopidogrel responsiveness in healthy subjects. Journal of thrombosis and haemostasis 5, 2153\u20132155 (2007).","journal-title":"Journal of thrombosis and haemostasis"},{"key":"16310_CR12","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.jmoldx.2013.06.004","volume":"15","author":"SA Scott","year":"2013","unstructured":"Scott, S. A. et al. An Allele-Specific PCR System for Rapid Detection and Discrimination of the CYP2C19* 4A,* 4B, and * 17 Alleles: Implications for Clopidogrel Response Testing. The Journal of Molecular Diagnostics 15, 783\u2013789 (2013).","journal-title":"The Journal of Molecular Diagnostics"},{"key":"16310_CR13","doi-asserted-by":"crossref","unstructured":"Chae, H. et al. Feasibility of a microarray-based point-of-care CYP2C19 genotyping test for predicting clopidogrel on-treatment platelet reactivity. BioMed research international 2013 (2013).","DOI":"10.1155\/2013\/154073"},{"key":"16310_CR14","doi-asserted-by":"crossref","unstructured":"Gomes, A. M. et al. Pharmacogenomics of human liver cytochrome P450 oxidoreductase: multifactorial analysis and impact on microsomal drug oxidation. (2009).","DOI":"10.2217\/pgs.09.7"},{"key":"16310_CR15","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.ahj.2010.06.039","volume":"160","author":"KA Tiroch","year":"2010","unstructured":"Tiroch, K. A. et al. Protective effect of the CYP2C19* 17 polymorphism with increased activation of clopidogrel on cardiovascular events. American heart journal 160, 506\u2013512 (2010).","journal-title":"American heart journal"},{"key":"16310_CR16","first-page":"266","volume":"26","author":"ACA Irina-Iuliana Costache","year":"2015","unstructured":"Irina-Iuliana Costache, A. C. A. Screening methods using clopidogrel by genotyping CYP2C19 cytochrome and ABCB1 gene in patients with acute coronary syndromes. Biomedical Research 26, 266\u2013272 (2015).","journal-title":"Biomedical Research"},{"key":"16310_CR17","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ahj.2014.03.006","volume":"168","author":"TO Bergmeijer","year":"2014","unstructured":"Bergmeijer, T. O. et al. CYP2C19 genotype\u2013guided antiplatelet therapy in ST-segment elevation myocardial infarction patients\u2014Rationale and design of the Patient Outcome after primary PCI (POPular) Genetics study. American heart journal 168, 16\u201322.e11 (2014).","journal-title":"American heart journal"},{"key":"16310_CR18","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1016\/S0140-6736(12)60161-5","volume":"379","author":"JD Roberts","year":"2012","unstructured":"Roberts, J. D. et al. Point-of-care genetic testing for personalisation of antiplatelet treatment (RAPID GENE): a prospective, randomised, proof-of-concept trial. The Lancet 379, 1705\u20131711 (2012).","journal-title":"The Lancet"},{"key":"16310_CR19","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1373\/49.6.853","volume":"49","author":"CT Wittwer","year":"2003","unstructured":"Wittwer, C. T., Reed, G. H., Gundry, C. N., Vandersteen, J. G. & Pryor, R. J. High-resolution genotyping by amplicon melting analysis using LCGreen. Clinical chemistry 49, 853\u2013860 (2003).","journal-title":"Clinical chemistry"},{"key":"16310_CR20","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.jmoldx.2013.04.005","volume":"15","author":"L Zhang","year":"2013","unstructured":"Zhang, L. et al. Comparison of high-resolution melting analysis, TaqMan Allelic discrimination assay, and sanger sequencing for Clopidogrel efficacy genotyping in routine molecular diagnostics. The Journal of molecular diagnostics: JMD 15, 600\u2013606, https:\/\/doi.org\/10.1016\/j.jmoldx.2013.04.005 (2013).","journal-title":"The Journal of molecular diagnostics: JMD"},{"key":"16310_CR21","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1136\/pgmj.2007.065193","volume":"84","author":"M Srinivasan","year":"2008","unstructured":"Srinivasan, M. & Smith, D. Drug interaction with anti-mycobacterial treatment as a cause of clopidogrel resistance. Postgraduate medical journal 84, 217\u2013219, https:\/\/doi.org\/10.1136\/pgmj.2007.065193 (2008).","journal-title":"Postgraduate medical journal"},{"key":"16310_CR22","doi-asserted-by":"crossref","first-page":"15419","DOI":"10.1016\/S0021-9258(17)40694-6","volume":"269","author":"S De Morais","year":"1994","unstructured":"De Morais, S. et al. The major genetic defect responsible for the polymorphism of S-mephenytoin metabolism in humans. Journal of Biological Chemistry 269, 15419\u201315422 (1994).","journal-title":"Journal of Biological Chemistry"},{"key":"16310_CR23","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1111\/j.1538-7836.2010.03921.x","volume":"8","author":"D Sibbing","year":"2010","unstructured":"Sibbing, D. et al. Isolated and interactive impact of common CYP2C19 genetic variants on the antiplatelet effect of chronic clopidogrel therapy. Journal of thrombosis and haemostasis: JTH 8, 1685\u20131693, https:\/\/doi.org\/10.1111\/j.1538-7836.2010.03921.x (2010).","journal-title":"Journal of thrombosis and haemostasis: JTH"},{"key":"16310_CR24","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1001\/jama.2011.1703","volume":"306","author":"JL Mega","year":"2011","unstructured":"Mega, J. L. et al. Dosing clopidogrel based on CYP2C19 genotype and the effect on platelet reactivity in patients with stable cardiovascular disease. Jama 306, 2221\u20132228 (2011).","journal-title":"Jama"},{"key":"16310_CR25","doi-asserted-by":"publisher","first-page":"399","DOI":"10.3109\/09537104.2011.579648","volume":"22","author":"G Campo","year":"2011","unstructured":"Campo, G. et al. Genetic determinants of on-clopidogrel high platelet reactivity. Platelets 22, 399\u2013407 (2011).","journal-title":"Platelets"},{"key":"16310_CR26","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1146\/annurev.pharmtox.41.1.815","volume":"41","author":"HG Xie","year":"2001","unstructured":"Xie, H. G., Kim, R. B., Wood, A. J. & Stein, C. M. Molecular basis of ethnic differences in drug disposition and response. Annual review of pharmacology and toxicology 41, 815\u2013850, https:\/\/doi.org\/10.1146\/annurev.pharmtox.41.1.815 (2001).","journal-title":"Annual review of pharmacology and toxicology"},{"key":"16310_CR27","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.amjcard.2009.02.045","volume":"104","author":"JM Lee","year":"2009","unstructured":"Lee, J. M. et al. Relation of genetic polymorphisms in the cytochrome P450 gene with clopidogrel resistance after drug-eluting stent implantation in Koreans. The American journal of cardiology 104, 46\u201351, https:\/\/doi.org\/10.1016\/j.amjcard.2009.02.045 (2009).","journal-title":"The American journal of cardiology"},{"key":"16310_CR28","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1161\/CIRCULATIONAHA.109.885194","volume":"121","author":"D Sibbing","year":"2010","unstructured":"Sibbing, D. et al. Cytochrome 2C19*17 allelic variant, platelet aggregation, bleeding events, and stent thrombosis in clopidogrel-treated patients with coronary stent placement. Circulation 121, 512\u2013518, https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.109.885194 (2010).","journal-title":"Circulation"},{"key":"16310_CR29","doi-asserted-by":"publisher","first-page":"2346","DOI":"10.1161\/01.STR.0000185703.88944.7d","volume":"36","author":"K Ranade","year":"2005","unstructured":"Ranade, K. et al. Evaluation of the paraoxonases as candidate genes for stroke: Gln192Arg polymorphism in the paraoxonase 1 gene is associated with increased risk of stroke. Stroke; a journal of cerebral circulation 36, 2346\u20132350, https:\/\/doi.org\/10.1161\/01.STR.0000185703.88944.7d (2005).","journal-title":"Stroke; a journal of cerebral circulation"},{"key":"16310_CR30","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/nm.2281","volume":"17","author":"HJ Bouman","year":"2011","unstructured":"Bouman, H. J. et al. Paraoxonase-1 is a major determinant of clopidogrel efficacy. Nature medicine 17, 110\u2013116, https:\/\/doi.org\/10.1038\/nm.2281 (2011).","journal-title":"Nature medicine"},{"key":"16310_CR31","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/S0022-3565(24)29643-9","volume":"297","author":"M Tanabe","year":"2001","unstructured":"Tanabe, M. et al. Expression of P-glycoprotein in human placenta: relation to genetic polymorphism of the multidrug resistance (MDR)-1 gene. The Journal of pharmacology and experimental therapeutics 297, 1137\u20131143 (2001).","journal-title":"The Journal of pharmacology and experimental therapeutics"},{"key":"16310_CR32","doi-asserted-by":"publisher","first-page":"3473","DOI":"10.1073\/pnas.97.7.3473","volume":"97","author":"S Hoffmeyer","year":"2000","unstructured":"Hoffmeyer, S. et al. Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proceedings of the National Academy of Sciences of the United States of America 97, 3473\u20133478, https:\/\/doi.org\/10.1073\/pnas.050585397 (2000).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"16310_CR33","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1373\/clinchem.2013.202689","volume":"59","author":"L Zhou","year":"2013","unstructured":"Zhou, L. et al. Symmetric snapback primers for scanning and genotyping of the cystic fibrosis transmembrane conductance regulator gene. Clinical chemistry 59, 1052\u20131061 (2013).","journal-title":"Clinical chemistry"},{"key":"16310_CR34","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1373\/clinchem.2003.029751","volume":"50","author":"GH Reed","year":"2004","unstructured":"Reed, G. H. & Wittwer, C. T. Sensitivity and specificity of single-nucleotide polymorphism scanning by high-resolution melting analysis. Clinical chemistry 50, 1748\u20131754 (2004).","journal-title":"Clinical chemistry"},{"key":"16310_CR35","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1373\/clinchem.2004.032136","volume":"50","author":"M Liew","year":"2004","unstructured":"Liew, M. et al. Genotyping of single-nucleotide polymorphisms by high-resolution melting of small amplicons. Clinical chemistry 50, 1156\u20131164 (2004).","journal-title":"Clinical chemistry"},{"key":"16310_CR36","first-page":"160","volume":"20","author":"MT Seipp","year":"2009","unstructured":"Seipp, M. T., Durtschi, J. D., Voelkerding, K. V. & Wittwer, C. T. Multiplex amplicon genotyping by high-resolution melting. J Biomol Tech 20, 160\u2013164 (2009).","journal-title":"J Biomol Tech"},{"key":"16310_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/1756-0500-5-69","volume":"5","author":"S Pereyra","year":"2012","unstructured":"Pereyra, S., Velazquez, T., Bertoni, B. & Sapiro, R. Rapid multiplex high resolution melting method to analyze inflammatory related SNPs in preterm birth. BMC research notes 5, 1 (2012).","journal-title":"BMC research notes"},{"key":"16310_CR38","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1128\/JCM.00874-15","volume":"53","author":"W Mazi","year":"2015","unstructured":"Mazi, W. et al. Rapid genotyping of Shigella sonnei by use of multiplex high-resolution melting. Journal of clinical microbiology 53, 2389\u20132391 (2015).","journal-title":"Journal of clinical microbiology"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-16310-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-16310-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-16310-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T01:24:36Z","timestamp":1750987476000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-16310-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,22]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["16310"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-16310-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,22]]},"assertion":[{"value":"22 February 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"16021"}}